Olema Pharmaceuticals, Inc.·4

Mar 3, 4:19 PM ET

Zojwalla Naseem 4

4 · Olema Pharmaceuticals, Inc. · Filed Mar 3, 2025

Insider Transaction Report

Form 4
Period: 2025-02-28
Zojwalla Naseem
CHIEF MEDICAL OFFICER
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-02-28+205,000205,000 total
    Exercise: $4.37Exp: 2035-02-27Common Stock (205,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the option vest on February 28, 2026 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.

Documents

1 file
  • 4
    form4-03032025_090328.xmlPrimary